Decheng Capital »

10x Genomics Inc Cl A shares owned by Decheng Capital

Quarter-by-quarter ownership of 10x Genomics Inc Cl A (TXG) shares owned by Decheng Capital from 13F filings

Historical chart of Decheng Capital investment in 10x Genomics Inc Cl A

Tip: Access up to 7 years of quarterly data

All positions including 10x Genomics Inc Cl A held by Decheng Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 10x Genomics Inc Cl A by Decheng Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $20M 360k 55.96

More positions owned by Decheng Capital

Alpine Immune Sciences (ALPN)
Zentalis Pharmaceuticals (ZNTL)
Pacific Biosciences of California (PACB)
10x Genomics Cl A Com (TXG)
ImmunoGen
Arcus Biosciences Incorporated (RCUS)
Karuna Therapeutics Ord
Roivant Sciences Ltd Shs Isin #bmg762791017 (ROIV)
Illumina (ILMN)
Argenx SE SHS (ARGX)
Acelyrin (SLRN)
Krystal Biotech (KRYS)
Phathom Pharmaceuticals (PHAT)
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH)
Terns Pharmaceuticals (TERN)

View all positions for Decheng Capital

Top funds holding 10x Genomics Inc Cl A

Vanguard Group
Baillie Gifford & Co
ARK Investment Management
Sumitomo Mitsui Trust Holdings
T. Rowe Price Associates
Nikko Asset Management Americas
Venrock Management VI
Jpmorgan Chase & Co
Bp Wealth Management
Credit Suisse
Charles Schwab Investment Management
Bank of New York Mellon
Damian Sousa
Alyeska Investment Group
SRS Investment Management

View all funds holding 10x Genomics Inc Cl A